4//SEC Filing
Detke Michael J. 4
Accession 0001209191-20-032970
CIK 0001662774other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:48 PM ET
Size
10.9 KB
Accession
0001209191-20-032970
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
Detke Michael J.
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-05-27−5,515→ 104,091 totalExercise: $6.91Exp: 2029-02-05→ Common Stock (5,515 underlying) - Exercise/Conversion
Common Stock
2020-05-27$6.91/sh+5,515$38,109→ 28,261 total
Footnotes (1)
- [F1]The option vested as to 25% of the shares on December 16, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on January 16, 2020 and ending on December 16, 2022.
Issuer
Cortexyme, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001770786
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:48 PM ET
- Size
- 10.9 KB